Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-7.32%
+0.14%
-1.99%
-3.06%
CAN
Canaan
$1.32
Login to see Canaan (CAN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Upgraded on attractively valued
Chart
$0.71 (+85.92%)
$0.72 (+83.33%)
$0.88 (+50.00%)
$0.96 (+37.50%)
CAN has High Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
High volatilty
CAN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a weak earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
CAN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CAN Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayCAN Earnings
The TTM reflects 12-month period, providing review of CAN financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is CAN current stock price?
What are CAN stock strengths?
What risks are associated with CAN stock?
When is CAN next earnings report?
What is CAN market cap and volume?
What is CAN's current Stock IQ?
Should I buy CAN stock right now?
Is CAN a Strong Buy right now?
What does a 'Strong Buy' rating mean for CAN?
What does a 'Strong Sell' rating mean for CAN?
What factors influence CAN's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.32%
+0.14%
-1.99%
-3.06%
CAN
Canaan
Current Price
$1.32
Stock Insights
Strengths
Upgraded on attractively valued
Login to unlock Canaan (CAN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$0.71 (+85.92%)
$0.72 (+83.33%)
$0.88 (+50.00%)
$0.96 (+37.50%)
CAN Analysts Opinion
CAN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a weak earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
CAN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CAN Street view is extremely bullish and have negative views on the near-term outlook
CAN has High Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
High volatilty
Average key support and resistance price levels.
Login to displayCAN Earnings
The TTM data reflects the most recent 12-month period, providing overview of CAN financial performance.
CAN Financial Health
The company financial health has moderately improved over the past year
Financial Score
CAN Latest Analysis
Taysha Gene Therapies Canaan Ondas Holdings And Other Big Stocks Moving Higher On Thursday. United States stocks were mixed with the Dow Jones index falling more than 50 points on Thursday.Shares of TSHA) rose sharply during Thursday'.s session after the FDA granted the company Breakthrough Therapy designation to TSHA-102 for the treatment of Rett syndrome.Needham analyst Gil Blum maintained Taysha Gene Therapies with a Buy and raised the price target from $8 to $10.Taysha Gene Therapies sha
Today
Canaan secures order for Avalon A15 Pro mining machines. shares up over 7%.
Today
Canaan Stock Jumps 25% on Largest Bitcoin Miner Order in 3 Years.
Today
Soluna Partners Canaan To Deploy 20 MW Next-Gen Bitcoin Miners At Wind-Powered Data Center In Texas . (RTTNews) - Soluna Holdings Inc. (SLNH) a developer of green data centers and Singapore-based computer hardware manufacturer Canaan Inc. (CAN) announced a strategic hosting agreement to deploy 20 megawatts (MW) of Avalon A15 XP Bitcoin miners at Solunas Project Dorothy in Br
Tue Sep 30, 2025
Expert Outlook: Canaan Through The Eyes Of 7 Analysts. 7 analysts have expressed a variety of opinions on Canaan (NASDAQ:) over the past quarter offering a diverse set of opinions from ish to bearish.The table below summarizes their recent ratings showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.6010010000200000000030100Analysts provide deeper insights through their assessments of 12-month price targets revealing an average target of $3.64 a h
Fri Sep 12, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings